Drug Stocks Mostly Higher (JNJ, KERX, MRK, ENDP, CVM)

Houston, TX -- (SBWIRE) -- 01/31/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

Johnson & Johnson(NYSE:JNJ) fell 0.03% and is trading at $74.07. Johnson & Johnson is a holding company. The Company, along with its subsidiaries, is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.

Can JNJ Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

Keryx Biopharmaceuticals(NASDAQ:KERX) added 10.48% and is trading at $9.38. Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.

How Should Investors Trade KERX After The Recent Volatile Moves? Find Out Here

Merck & Co., Inc.(NYSE:MRK) is higher 0.18% and is trading at $43.58. Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company’s operations are principally managed on a products basis and consists of four segments: the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment: the Pharmaceutical segment.

Is MRK Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here

Endo Health Solutions Inc(NASDAQ:ENDP) added 2.84% and is trading at $32.56. Endo Health Solutions Inc., formerly Endo Pharmaceuticals Holdings Inc., is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company operates in four segments: Branded Pharmaceuticals, Generics, Devices and Services in therapeutic areas, including pain and urology.

Can ENDP Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

CEL-SCI Corporation(NYSEAMEX:CVM) is higher 3.69% and is trading at $0.284. CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.

Is CVM Ready To Move Back To New Highs This Year? Find Out Here

Disclaimer
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information
Winning Media LLC
1-800-411-7716
ir@AnotherWinningTrade.com